Plasma Protein Therapeutic Market Development Status, Opportunities, And Growth By Forecast 2028

Plasma protein treatment is extensively used to treat well-defined medical conditions, replacing missing or deficient proteins found in plasma, to allow their recipients to lead healthier and more productive lives. The patient populations that rely upon plasma protein therapies generally require regular infusions or injections for the duration of their lives. Plasma proteins therapies are significantly utilised in replacement therapies for the treatment of conditions, like deficiency of a coagulation factor in the field of hemostasis. coagulation factor deficiency can be genetic or can occur due to autoimmune disorder. It can also occur as a complication of cancer. Fibrinogen is extensively used as a replacement therapy for treatment of hemorrhagic diathesis in diseases, for instance dysfibrinogenemia, afibrinogenemia, and hypofibrinogenemia.

To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/10142-plasma-protein-therapeutic-market-report

PLASMA PROTEIN THERAPEUTIC MARKET OUTLOOK

The plasma protein therapeutics market is principally driven by growing prevalence of immune deficiency disorders, autoimmune disorders, neurological and bleeding disorders. In addition, the rise in geriatric population who are more prone to disorders. For instance, as per the statistics published by the National Institute of Health (NIH), around 23.5 million people in U.S. alone suffer from autoimmune disease thereby leading to increasing need of developing treatment procedures and devices.

Besides, the increasing investments in research and development programs by the biotechnology and pharmaceutical companies is likely to boost the growth of the market. The ongoing research and development in the plasma protein segment are expected to drive its use through multiple applications. The extending use of therapeutic protein drugs in the treatment of a broad range of clinical symptoms are likely to offer numerous growth opportunities for plasma protein therapeutics market in forthcoming years. On the downside, lack of reimbursement and stringent regulation are likely to hamper the market growth to some extent.

PLASMA PROTEIN THERAPEUTIC MARKET SEGMENTAL OVERVIEW

The report analyses the global plasma protein therapeutic market based on product, application, and geography.

PLASMA PROTEIN THERAPEUTIC MARKET BY PRODUCT

The various commercially available plasma protein therapeutic products Albumin, Immunoglobulin, plasma-derived factor VIII. Albumin is globular protein found in blood plasma. Serum albumin is the most abundant plasma protein, constituting around 50% of human plasma protein. Albumin is obtained from plasma fractionation process where human serum albumin and bovine serum albumin is most widely used. The albumin segment is expected to grow at significant pace over the forecast period driven by improved diagnosis of hypoalbuminemia caused by liver cirrhosis and hepatitis B. High demand and usage in China, which is the largest market for albumin, is anticipated to further fuel the growth.

PLASMA PROTEIN THERAPEUTIC MARKET BY APPLICATION

Plasma protein therapeutics finds application in Hemophilia, Primary Immunodeficiency Diseases (PID), Idiopathic Thrombocytopenic Purpura (ITP), etc. Primary immunodeficiency diseases includes more than 200 rare, chronic diseases that result from a defect in the immune system. Primary immune deficiency diseases (PIDDs) are rare, genetic disorders that impair the immune system. Without a functional immune response, people with PIDDs may be subject to chronic, debilitating infections, such as Epstein-Barr virus (EBV), which can increase the risk of developing cancer. The PID segment is likely grow at a significant pace owing to the growing expansion of clinical applications for immunoglobulins, and high treatment costs etc.

PLASMA PROTEIN THERAPEUTIC MARKET BY GEOGRAPHY

In terms of region, the plasma protein therapeutics market is studied for the key regions including North America, Europe, Asia Pacific, and Rest of the World. North America region occupied for the largest market share if global plasma protein therapeutic market attributed to presence of large patient base and availability of well-developed infrastructure for storing and maintaining high-quality source plasma are major factors driving the growth of the market. On the other hand, Asia Pacific is likely to grow at a fastest pace over the forecast period owing to increased adoption of novel therapeutics, rising disease prevalence and high R&D investment serve as high growth drivers.

PLASMA PROTEIN THERAPEUTIC MARKET KEY PLAYERS

Key competitors of this market include Baxter International, Biotest, CSL Behring, GRIFOLS, S.A., Kedrion Octapharma USA, Inc., Shire Plc and China Biologics among others.

PLASMA PROTEIN THERAPEUTIC MARKET KEY DEVELOPMENTS

June 2016:  Shire Plc acquired Baxalta. Shire acquired Baxalta’s product portfolio and a strong pipeline for the treatment of rare diseases

August 2018:  Grifols S.A. acquired 24 plasma donor centers in the U.S. These are operated by Biotest AG

Buy now Plasma Protein Therapeutic Market Report https://www.axiommrc.com/buy_now/10142-plasma-protein-therapeutic-market-report

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

                 http://contactsnleads.com/

Blog: https://industrywatch24.com/

          https://readbeyondnews.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom

Comments

Post a Comment

Popular posts from this blog

Induced Pluripotent Stem Cells Market is anticipated to grow at a CAGR of 7.32% from 2022 to 2028

Image
Global Induced Pluripotent Stem Cells Market research report provides comprehensive information on the market. It also includes in-depth information about Market #Drivers, Opportunities, Market Restraints, Market Growth #Challenges and Cumulative #Growth Analysis. Moreover, the report also provides an in-depth analysis of the Induced Pluripotent Stem Cells Market by identifying key players. The report also examines the #competitive landscape of the Induced Pluripotent Stem Cells Market industry and analyses its impact on the growth of this market over the next few years. The segmental analysis focuses on revenue and forecast for the period 2019-2028.   Request PDF Sample Copy of Report @ https://www.axiommrc.com/request-for-sample/11226-induced-pluripotent-steam-cells-market-report   Axiom Market Research & Consulting™ added a report on Global Induced Pluripotent Stem Cells Market which includes study on derived cell type, product, process, application, end ...
Read more

Freeze Drying Equipment Market: Growth, Opportunities, and Future Outlook

Freeze Drying Equipment Market is segmented based on type, application, and region. The different types of freeze drying equipment include laboratory, pilot, and industrial-scale equipment. The applications of freeze drying equipment include food processing, pharmaceuticals, biotechnology, and others. The market is dominated by the pharmaceutical and biotechnology segments due to the high demand for freeze-dried drugs and vaccines.   Freeze drying, also known as lyophilization, is a dehydration process used to preserve perishable materials such as food, pharmaceuticals, and biologicals. Freeze drying equipment is used to carry out this process, which involves freezing the material and then removing the ice by sublimation. Freeze drying equipment is an essential tool for industries that require long-term storage of perishable materials. The global freeze drying equipment market is expected to grow at a significant rate in the coming years due to the increasing demand for freeze...
Read more

Future of Europe Infection Surveillance Solutions Market in 2022-2028

Image
Infection surveillance solutions are used to reduce several healthcare associated infections such as pneumonia (eg, ventilator-associated pneumonia [VAP]), bloodstream infection (BSI), urinary tract infection (UTI), and surgical site infection (SSI). It is also used to reduce other infections such as surgical wound infections, respiratory tract infections, and many others. A healthcare-associated infection is an infection whose development is favored by a hospital or other healthcare facilities environment, such as one acquired by a patient during a hospital visit To know the scope of our report get a sample  on https://www.axiommrc.com/request-for-sample/11021-europe-infection-surveillance-solutions-market-report MARKET DYNAMIC- EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET Primary driving factors such as the vast presence of developing as well as developed economies, increasing funding for improving the healthcare infrastructure and redevelopment of healthcare projects and s...
Read more